Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Orthopediatrics (KIDS) over the last 10 years, with Q3 2025 value amounting to $4.3 million.

  • Orthopediatrics' Share-based Compensation rose 838.86% to $4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.2 million, marking a year-over-year increase of 3903.44%. This contributed to the annual value of $13.5 million for FY2024, which is 2870.99% up from last year.
  • According to the latest figures from Q3 2025, Orthopediatrics' Share-based Compensation is $4.3 million, which was up 838.86% from $5.3 million recorded in Q2 2025.
  • Orthopediatrics' Share-based Compensation's 5-year high stood at $5.3 million during Q2 2025, with a 5-year trough of $1.3 million in Q1 2021.
  • For the 5-year period, Orthopediatrics' Share-based Compensation averaged around $2.6 million, with its median value being $2.4 million (2023).
  • Its Share-based Compensation has fluctuated over the past 5 years, first tumbled by 4328.66% in 2021, then skyrocketed by 8655.37% in 2023.
  • Over the past 5 years, Orthopediatrics' Share-based Compensation (Quarter) stood at $1.7 million in 2021, then increased by 1.73% to $1.7 million in 2022, then skyrocketed by 61.49% to $2.7 million in 2023, then surged by 41.54% to $3.9 million in 2024, then increased by 9.34% to $4.3 million in 2025.
  • Its Share-based Compensation was $4.3 million in Q3 2025, compared to $5.3 million in Q2 2025 and $3.9 million in Q1 2025.